Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Polivka

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Brain Pathology (Zurich, Switzerland)|May 6, 2017
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysisArnault Tauziede-Espariat, Béatrice Parfait, Aurore Besnard, et al.
Journal of Neurosurgery|October 22, 2022
Management strategies in clival and craniovertebral junction chordomas: a 29-year experienceThibault Passeri, Pierre-Olivier Champagne, Lorenzo Giammattei, et al.
The American Journal of Surgical Pathology|March 19, 2015
Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalisFranck Bielle, Chiara Villa, Marine Giry, et al.
Thyroid : Official Journal of the American Thyroid Association|August 31, 2011
Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological controlBeatrix Cochand-Priollet, Henri Dahan, Marie Laloi-Michelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 25, 2020
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.
Acta Neuropathologica Communications|December 17, 2015
Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusionMelanie Pages, Ludovic Lacroix, Arnault Tauziede-Espariat, et al.
Annals of Neurology|July 29, 2005
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomasMichèle Kujas, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Cancers|March 25, 2022
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in <i>PBRM1</i>-Mutated Human Chordoma XenograftThibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, et al.
Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Brain Pathology (Zurich, Switzerland)|May 6, 2017
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysisArnault Tauziede-Espariat, Béatrice Parfait, Aurore Besnard, et al.
Journal of Neurosurgery|October 22, 2022
Management strategies in clival and craniovertebral junction chordomas: a 29-year experienceThibault Passeri, Pierre-Olivier Champagne, Lorenzo Giammattei, et al.
The American Journal of Surgical Pathology|March 19, 2015
Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalisFranck Bielle, Chiara Villa, Marine Giry, et al.
Thyroid : Official Journal of the American Thyroid Association|August 31, 2011
Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological controlBeatrix Cochand-Priollet, Henri Dahan, Marie Laloi-Michelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 25, 2020
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Correction: NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic markerRaul Perret, Julien Escuriol, Valérie Velasco, et al.
Acta Neuropathologica Communications|December 17, 2015
Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusionMelanie Pages, Ludovic Lacroix, Arnault Tauziede-Espariat, et al.
Annals of Neurology|July 29, 2005
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomasMichèle Kujas, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Cancers|March 25, 2022
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in <i>PBRM1</i>-Mutated Human Chordoma XenograftThibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, et al.
Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.
Pageof 10